SEVERAL WORKERS have demonstrated elaboration of physiologically important entities such as placental hormones by neoplastic cells (Braunstein et al., 1975) . The production of human placental lactogen (hPL) has been reported so far only in association with malignant tumours (Weintraub & Rosen, 1971; Gaspard et al., 1973; Rosen et al., 1975; Sheth et al., 1977) . Its presence in various noncancerous conditions has not been established except for one report on its detection in normal testes of a patient with prostate cancer (Payne & Ryan, 1972) .
The present communication deals with our investigations on the association of hPL, if any, with fibroadenoma of breast, a benign tumour. Using a sensitive radioimmunoassay (RIA) for hPL, extracts of tumour samples as well as pre-and postoperative sera from patients were examined. The results indicate association of hPL with fibroadenoma of the breast in a significant proportion of the patients.
Patients.-Women included in these investigations were those examined at the Tata Memorial Hospital, Bombay. Clinically, all the patients had hard, freely mobile, small-to-medium-size nodules in the substance of the breast, but no palpable axillary nodes Greenwood et al. (1963) as modified by Midgley (1966) . The specific activity of the labelled hormone was 100-150/,uCi/pg. The assay procedure was the same as described by Sheth et al. (1977) . All the serum samples and tissue extracts were examined in duplicate, using aliquots of 200 and 400 pl per assay tube. The samples were considered positive only when total precipitable counts were less than 80% of the counts in zero-antigen tubes (Figure) . The sensitivity of the assay was 0 3 ng per assay tube. The intra-assay variation of the results was < 2% and the inter-assay variation was < 5%. All samples were assayed within 30 days of collection.
As can be seen from the values given in Table I , none of the serum samples from non-pregnant women or normal men contained hPL, whereas 9/30 patients (30%) with fibroadenomas yielded serum samples containing hPL in the range 1-5.6 ng/ml. Table II gives the data on tissue extracts and pre-and post-operative sera from the corresponding patients. Out of 21 patients examined for their tumour extracts, 9 were positive (negative patients are not included in the Table) . 
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bilateral tumours) with hPL+ tumours also showed hPL in their preoperative sera. On the other hand, the 12 patients (9 with unilateral and 3 with bilateral tumours) whose tumours had no hPL had no detectable hPL in circulation. Furthermore, the postoperative sera collected from 7 out of 9 patients with hPL in their tumours and preoperative sera became hPL-when examined between 1 week to 6 months after excision of fibroadenoma. Ectopic secretion of hPL by benign tumours has not been reported so far. In the present investigations, however, the sensitive RIA detected hPL in a significant proportion of tumour samples and preoperative sera from patients with fibroadenoma of the breast. Control samples assayed simultaneously with the same reagents gave no false-positive results. Moreover, the inhibition curves for hPL+ extracts and sera were parallel to those obtained with standard hPL samples.
The presence of hPL in tumour extracts and preoperative sera, and its nondetectability in the postoperative sera, provide indirect evidence for the elaboration of hPL by the tumours.
Interestingly, the studies on bilateral fibroadenomas (Table II) showed that the tumours from both the breasts were hPL+. Positive results with bilateral tumours suggest the possibility of a common factor governing the ectopic secretion in both the tumours. Another interesting observation from the present investigation is that normal breast tissue adjacent to hPL+ fibroadenoma was negative for hPL in all I One value from each bilateral fibroadenoma.
6 patients examined. In contrast, similar tissue adjacent to carcinoma of breast revealed hPL whenever the carcinoma had detectable hPL (unpublished observation). The fact that fibroadenoma is well delineated from the surrounding breast tissue indicates encapsulation (Haagensen, 1971) which may be responsible for the absence of hPL in tissue adjacent to hPL+ fibroadenoma. Our detection of circulating hPL in fibroadenoma patients contrasts with similar studies by Rosen et al. (1975) and Sheth et al. (1977) . Both those reports, however, dealt with smaller numbers of patients.
It may be of interest that RIA of a hCG carried out at the same sensitivity level as for hPL did not reveal fi hCG in sera of patients with fibroadenoma of breast, and confirmed our earlier observations (Sheth et al., 1974) . Greater secretion of hPL than hCG by fibroadenomas of breast is noteworthy. hPL is known to be mammotrophic in lower animals and stimulatory for mammary-gland growth and dysplasia in mice (Yanai & Nagasawa, 1973) . Recent reports provide evidence for hPLmediated stimulation of DNA synthesis in organ cultures of benign human breast tumours (Welsch et at., 1978) and mitogenicity of hPL for ductal epithelium in human benign breast tumours grown in organ culture (Welsch et at., 1978) and in athymic nude mice (McManus et al., 1978) . These reports suggest a key role for hPL in the aetiology of human benign breast tumours. It is possible that hPL secreted by fibroadenoma plays a local role in tumour growth.
